Founded in 2001, we are a clinical-stage biopharmaceutical company focused on delivering ground-breaking cancer therapeutics to patients globally. We leverage our deep expertise in oncology-focused novel therapeutics for the benefit of cancer patients everywhere. We aspire to improve the lives of patients by ensuring access to quality cancer medicines through accelerated innovation and strong partnerships.
Murali has been an integral part of Aurigene since February 2005. Before assuming the role of CEO, he served as Chief Scientific Officer at …
Susanta Samajdar serves as the Chief Scientific Officer at Aurigene Oncology Limited, bringing over 25 years of experience in synthetic and …
Akhil leads the clinical development department at Aurigene. After completing his MBBS from AIIMS, New Delhi, in 1995, he completed his resi…
Brijesh is a Chartered Accountant with 20+ years of experience in Accounting, Financial Management, Internal Auditing and Project Management…
Sanjeev has over 20 years of experience in the field of new drug development and clinical research. He has successfully led multidisciplinar…
Subir has around 30 years of experience in international business development and formulation of business strategy. He has unique mix of exp…
Veerendra, as the Head of Human Resources at Aurigene, is responsible for driving the human resources strategies aligning with organizationa…
G V Prasad is the Co-chairman and Managing Director of Dr. Reddy’s Laboratories Ltd. He is widely credited as the architect of Dr. Reddy’s s…
Every check below comes straight from official government records — badges here can't be bought.
Limited government data available — 5 criteria met
Government-registered export credentials verified from DGFT and MCA registries.
AURIGENE ONCOLOGY LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
AURIGENE ONCOLOGY LIMITED is a government-verified manufacturer of metals & chemicals based in Bangalore, Karnataka, India. It was incorporated in 2001 per Ministry of Corporate Affairs records (CIN U24239KA2001PLC029391). BharatSeal verifies it against MCA — official Indian government registries. Its BharatSeal trust score is 50 out of 100.
Oncology, Cancer Therapeutics
Bangalore, KA, India
Yes — verified across MCA (government registries including MCA, GSTN). CIN: U24239KA2001PLC029391.
AURIGENE ONCOLOGY LIMITED was incorporated in 2001 per Ministry of Corporate Affairs records under CIN U24239KA2001PLC029391. The company has been operating for 25 years, with the registration auditable on mca.gov.in.
AURIGENE ONCOLOGY LIMITED's current directors include Satish Reddy, M V Ramana, Dr. Bruce Carter, and 3 others. Director records are sourced from the MCA21 corporate registry and reflect the latest filing with the Ministry of Corporate Affairs.
50 out of 100. BharatSeal's trust score is computed from the breadth of government registrations the entity carries (MCA + GSTN + Udyam + IEC + EPFO), the freshness of those records, and the entity's interaction history on the platform (orders completed, on-time delivery rate, dispute outcomes). Buyers use this number to triage suppliers at scale.
Yes — exports to USA, Europe, Latin America, Middle East, Africa, Asia.
Send an inquiry through BharatSeal — verified suppliers typically respond within 2 hours, often on WhatsApp. Every enquiry is logged so you have a record of the conversation.
Other verified manufacturers in the same network — discovered via MCA21 cross-references.